These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3282654)

  • 21. Alloantigen-activated lymphocytes from mice bearing a spontaneous "nonimmunogenic" adenocarcinoma inhibit its growth in vivo by recruiting host immunoreactivity.
    Giovarelli M; Santoni A; Forni G
    J Immunol; 1985 Nov; 135(5):3596-603. PubMed ID: 3930610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The in vitro induction of delayed-type hypersensitivity to allo-antigens of the mouse.
    Barrington-Leigh J
    J Immunol Methods; 1984 Apr; 69(2):149-63. PubMed ID: 6232322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of syngeneic fibrosarcoma growth by lymphocytes sensitized on tumor-cell monolayers in the presence of the thymic humoral factor.
    Small M; Trainin N
    Int J Cancer; 1975 Jun; 15(6):962-72. PubMed ID: 1150350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The induction of lymphocytes with the capacity to render macrophages cytotoxic in an allogeneic murine system.
    De Weger RA; Pels E; Den Otter W
    Immunology; 1982 Nov; 47(3):541-50. PubMed ID: 6215342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assembly of transferred normal spleen cells in situ at sites eliciting the delayed hypersensitivity reaction to tumor antigens in mice.
    Abe S; Takahashi K; Yamazaki M; Mizuno D
    Gan; 1984 May; 75(5):442-7. PubMed ID: 6745564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transplantation of Graft Anti-Host Cytotoxic T Lymphocytes Along with Allogeneic Bone Marrow Skips Macrophage-Induced Graft-Versus-Host Disease.
    Yoshida R; Yamana H; Hayashi M; Yasuda E; Shibayama Y; Hirose Y; Tanigawa N; Uchiyama K; Kubota T
    J Interferon Cytokine Res; 2021 Sep; 41(9):310-318. PubMed ID: 34543129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of pertussis toxin (PT) on T-cell populations sensitized for delayed-type hypersensitivity in mice.
    Tamura SI; Nakanishi Y; Kojima A; Otokawa M; Uchida N; Sato H; Sato Y
    Cell Immunol; 1984 May; 85(2):351-63. PubMed ID: 6609000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of IL-16 in delayed-type hypersensitivity reaction.
    Yoshimoto T; Wang CR; Yoneto T; Matsuzawa A; Cruikshank WW; Nariuchi H
    Blood; 2000 May; 95(9):2869-74. PubMed ID: 10779433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concurrent depression of tumor macrophage infiltration and systemic inflammation by progressive cancer growth.
    Normann SJ; Cornelius J
    Cancer Res; 1978 Oct; 38(10):3453-9. PubMed ID: 99232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective transformation of host lymphocytes in vivo by retrovirus-producing macrophages.
    Bosco MC; Musso T; Gusella GL; Giovarelli M; Forni M; Soleti A; Masuelli L; Modesti A; Forni G; Varesio L
    J Immunol; 1993 Jan; 150(1):278-89. PubMed ID: 8417128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of delayed-type hypersensitivity-like responses in the mouse lung, determined with histological procedures: serotonin, T-cell suppressor-inducer factor and high antigen dose tolerance regulate the magnitude of T-cell dependent inflammatory reactions.
    Garssen J; Nijkamp FP; Wagenaar SS; Zwart A; Askenase PW; Van Loveren H
    Immunology; 1989 Sep; 68(1):51-8. PubMed ID: 2807371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impairment of allograft tumor immunity by isotype-like suppression of antigen-specific T cell factors.
    Van Loveren H; De Weger RA; Garssen J; Los G; Askenase PW
    Transplantation; 1989 Mar; 47(3):504-12. PubMed ID: 2466354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An early component of delayed-type hypersensitivity mediated by T cells and mast cells.
    van Loveren H; Meade R; Askenase PW
    J Exp Med; 1983 May; 157(5):1604-17. PubMed ID: 6602201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor suppression by a lymphokine released into the circulation of mice with delayed hypersensitivity.
    Salvin SB; Youngner JS; Nishio J; Neta R
    J Natl Cancer Inst; 1975 Nov; 55(5):1233-6. PubMed ID: 1206752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Delayed-type hypersensitivity is mediated by a sequence of two different T cell activities.
    Van Loveren H; Askenase PW
    J Immunol; 1984 Nov; 133(5):2397-401. PubMed ID: 6332849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of class II-MHC antigens by tumor-associated and peritoneal macrophages: systemic induction during tumor growth and tumor rejection.
    Evans R; Blake SS; Saffer JD
    J Leukoc Biol; 1986 Nov; 40(5):499-509. PubMed ID: 3464672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunologic rejection of diethylnitrosamine-induced hepatomas in strain 2 guinea pigs: participation of basophilic leukocytes and macrophage aggregates.
    Dvorak HF; Dvorak AM; Churchill WH
    J Exp Med; 1973 Mar; 137(3):751-75. PubMed ID: 4347597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of in situ host immunity to syngeneic tumors utilizing the multicellular spheroid model.
    Lord EM; Burkhardt G
    Cell Immunol; 1984 May; 85(2):340-50. PubMed ID: 6713544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rejection of mammary adenocarcinoma cell tumors in DBA/2 mice immunocompromised by thymectomy and treatment with antithymocyte serum.
    Likhite VV
    J Immunol; 1975 Jun; 114(6):1736-42. PubMed ID: 1092759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adoptive immunotherapy of a BALB/c lymphoma by syngeneic anti-DBA/2 immune lymphoid cells: characterization of the effector population and evidence for the role of the host's non-T cells.
    Colombo MP; Parenza M; Parmiani G
    Cancer Immunol Immunother; 1985; 20(3):198-204. PubMed ID: 3851699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.